Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Virus+Diseases%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Virus+Diseases%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Virus+Diseases%22&type=Subject
PubPharm (2.713)
1
A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above : A Phase 3b, Open-label Study to Evaluate the Non-inferiority of the Immune Response and to Evaluate the Safety of the RSVPreF3 OA Investigational Vaccine in Adults 18-49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults >=60 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Efficacy and Safety of XC8, Film-coated Tablets, in Children With Acute Respiratory Viral Infections : Double-blind Placebo-controlled Multicenter Randomized Clinical Trial to Evaluate the Efficacy and Safety of XC8, Film-coated Tablets (Valenta Pharm JSC, Russia), in Children Aged 6-17 Years With Dry Non-productive Cough Against the Background of Acute Respiratory Viral Infection
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age : A Phase 3 Randomized, Observer-Blind, Study to Evaluate Safety, Tolerability, and Immunogenicity of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus (RSV), When Given Alone or Coadministered With a Seasonal Influenza Vaccine or SARS-CoV-2 Vaccine and When Given as an Open-label Boost at 1 Year Following a Primary Dose in Adults ≥ 50 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
A Study to Investigate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-risk Adults : A Phase 3 Study to Evaluate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-Risk Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study to Investigate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-risk Adults : A Phase 3 Study to Evaluate the Immunogenicity and Safety of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in High-Risk Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Oral Ivermectin for Chikungunya Viral Infection : A Randomized Controlled Trial of Oral Ivermectin for Patients With Chikungunya Viral Infection During Urban Outbreak in Southern Thailand
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
A Study of AK0529 in Chinese Infants Hospitalized With RSV : A Randomized, Double-blind, Placebo-controlled, 2-part Study of Orally Administered AK0529 to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Antiviral Effect of Multiple Doses in Hospitalized Infants With Respiratory Syncytial Virus Infection
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza : Double-blind Placebo-controlled Randomized Trial of Efficacy and Safety of Cycloferon, Enteric-coated Tablets, 150 mg, for Post-exposure Prophylaxis of Acute Respiratory Viral Infection and Influenza
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like Disease : A Randomized, Double-blind, Parallel, Placebo-control Study to Evaluate the Efficacy and Safety of "Formosa 1-Breath Free (NRICM101) " in Subjects With the Symptoms of COVID-19 or Influenza-like
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
10
Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination With the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC : Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination With the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC: a Mix-and-match Phase II RCT
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[272]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Thema: Phase: Phase 3
Medienart
2.713
Aufsätze
2.713
E-Artikel
E-Ressourcen
Zeitschriftentitel
2.608
WHO International Clinical Trials Registry Plat...
105
ClinicalTrials.gov
Thema
2.713
610
Phase: Phase 3
2.713
Study Type: Interventional
1.700
Recruitment Status: Not yet recruiting
802
Recruitment Status: Authorised-recruitment may ...
105
Virus Diseases
75
Recruitment Status: Completed
64
Medical Condition: Influenza A Infection MedDRA...
42
Medical Condition: Human Immunodeficiency Virus...
40
Medical Condition: Human Immunodeficiency Virus...
32
Communicable Diseases
28
Medical Condition: HIV-1 infection MedDRA versi...
25
Hepatitis
24
Hepatitis A
24
Infection
24
Medical Condition: COVID-19;Therapeutic area: D...
24
Medical Condition: Prophylaxis of Influenza Med...
24
Medical Condition: Respiratory Syncytial Virus ...
24
Medical Condition: The prevention of medically ...
20
Hepatitis C
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.587
2020-
1.125
2010-2019
1
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.681
Englisch
20
Unbestimmt
6
Französisch
4
Spanisch
2
Deutsch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...